| Identification | Back Directory | [Name]
DCG04 | [CAS]
314263-42-8 | [Synonyms]
DCG04
CS-96
CD892
CD-892
CD 892
N-[[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl]-L-leucyl-L-tyrosyl-6-aminohexanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysinamide
L-LysinaMide,N-[[(2S,3S)-3-(ethoxycarbonyl)-2-oxiranyl]carbonyl]-L-leucyl-L-tyrosyl-6-aMinohexanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]iMidazol-4-yl]-1-oxopentyl]-
ETHYL 3-((4S,7S,17S)-17-CARBAMOYL-7-(4-HYDROXYBENZYL)-2-METHYL-5,8,15,23-TETRAOXO-27-(2-OXO-HEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)-6,9,16,22-TETRAAZAHEPTACOSAN-4-YLCARBAMOYL)OXIRANE-2-CARBOXYLATE | [Molecular Formula]
C43H66N8O11S | [MDL Number]
MFCD10687085 | [MOL File]
314263-42-8.mol | [Molecular Weight]
903.1 |
| Hazard Information | Back Directory | [Description]
DCG04 is an activity-based probe for cysteine cathepsins, which enabled fluorescent readout of its receptor-targeting properties. | [Uses]
DCG04 is a substance for the development of an isotope-coded activity-based probe for quantitative profiling of cysteine proteases. Receptor-mediated targeting of cathepsins in professional antigen presenting cells. Also applied in the chemical approaches for functionally probing proteome. |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|